Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood

References

• Didkowska J, Wojciechowska U, Mańczuk M, Łobaszewski J. Lung cancer epidemiology: contemporary and future challenges worldwide. Ann Transl Med. 2016;4. doi:10.21037/atm2016.03.1126855940
   PubMed Web of Science ®Google Scholar
• Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med. 2005;172(5):523–529. doi:10.1164/rccm.200504-531OE15961694
   PubMed Web of Science ®Google Scholar
• Clark GM. Prognostic factors versus predictive factors: examples from a clinical trial of erlotynib. Mol Oncol. 2008;1(4):406–412. doi:10.1016/j.molonc.2007.12.00119383314
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Wehnl B, Hettwer K, et al. Carcinoembryonic antigen and cytokeratin-19 fragments for assessment of therapy response in non-small cell lung cancer: a systematic review and meta-analysis. Br J Cancer. 2017;116(8):1037–1045. doi:10.1038/bjc.2017.4528278517
   PubMed Web of Science ®Google Scholar
• Mahar AL, Compton C, McShane LM, et al. Refining prognosis in lung cancer. J Thor Oncol. 2015;10(11):1576–1589. doi:10.1097/JTO.0000000000000652
   PubMed Web of Science ®Google Scholar
• Itazawa T, Tamaki Y, Komiyama T, et al. The Japan Lung Cancer Society–Japanese Society for Radiation Oncology consensus-based computed tomographic atlas for defining regional lymph node stations in radiotherapy for lung cancer. J Radiat Resp. 2017;58(1):86–105. doi:10.1093/jrr/rrw076
   PubMed Web of Science ®Google Scholar
• Mountion CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest. 1997;111(6):1718–1723. doi:10.1378/chest.111.6.17189187199
   PubMed Web of Science ®Google Scholar
• Brundage MD, Davies D, Mackillop WJ. Prognostic factors in non-small cell lung cancer a decade of progress. Chest. 2002;122(3):1037–1057. doi:10.1378/chest.122.3.103712226051
   PubMed Web of Science ®Google Scholar
• Visnivesky JP, Halm EA. Sex differences in lung cancer survival; do tumors behave differently in elderly women. J Clin Oncol. 2007;25(13):1705–1712. doi:10.1200/JCO.2006.08145517470862
   PubMed Web of Science ®Google Scholar
• Ulas A, Tokluoglu S, Kos S, et al. Lung cancer in woman, a different disease; survival differences by sex in Turkey. Asian Pac J Cancer Prev. 2015;16(2):815–822. doi:10.7314/APJCP.2015.16.2.81525684531
   PubMedGoogle Scholar
• Song X, Chen D, Yuan M, et al. Total lymphocyte count, neutrophil-lymphocyte ratio, and platelet-lymphocyte ratio as prognostic factors in advanced non-small cell lung cancer with chemoradiotherapy. Cancer Manag Res. 2018;10:6677–6683. doi:10.2147/CMAR.S18857830584362
   PubMed Web of Science ®Google Scholar
• Qiang G, Liang C, Xiao F, et al. Prognostic significance platelet-to-lymphocyte ratio in non-small-cell lung cancer: a meta-analysis. Onco Targets Ther. 2016;9:869–876. doi:10.2147/OTT.S9680426955285
   PubMed Web of Science ®Google Scholar
• Sayan M, Kankoc A, Ozkan ND, et al. Simple peripheral blood cell parameters to predict prognosis in non-small cell lung cancer. Indian J Surg. 2020. doi:10.1007/s12262-020-02237-4
   Web of Science ®Google Scholar
• Lee MB, Rodrigeuz A, Mena G, et al. Platelet-to-lymphocyte ratio and use of NSAIDs during perioperative period as prognostic indicators in patients with NSCLC undergoing surgery. Cancer Control. 2016;23(3):284–294. doi:10.1177/10732748160230031227556669
   PubMed Web of Science ®Google Scholar
• Xu F, Xu P, Cui W, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid and identifying patients with non-small cell lung cancer and predicting tumor-node-metastases stage. Oncol Lett. 2018;16:483–489. doi:10.3892/ol.2018.864429928436
   PubMed Web of Science ®Google Scholar
• Toda M, Tsukioka T, Isumi N, et al. Platelet-to-lymphocyte ratio predict the prognosis of patient with non-small cell lung cancer treated with surgery and postoperative adjuvant chemotherapy. Thorac Cancer. 2018;9(1):112–119. doi:10.1111/1759-7714.1254729105365
   PubMed Web of Science ®Google Scholar
• Yu Y, Qian L, Cui J. Value of neutrophil-to-platelet ratio for predicting lung cancer prognosis: a meta-analysis of 7219 patients. Mol Clin Oncol. 2017;7(3):498–506. doi:10.3892/mco.2017.134228811903
   PubMed Web of Science ®Google Scholar
• Li J, Yang X, Ma J, et al. Relationship of Red blood cell distribution width with cancer mortality in hospital. Biomed Res Int. 2018:14. doi:10.1155/2018/8914617.
   Web of Science ®Google Scholar
• Hu L, Li M, Ding Y, et al. Prognostic value of RDW in cancers: a systemic review and meta-analysis. Oncotarget. 2017;8(9):16027–16035. doi:10.18632/oncotarget.1378427926498
   PubMedGoogle Scholar
• Koma Y, Onishi A, Matsuoka H, et al. Increased red blood cell distribution width associates with cancer stage and prognosis in patients with lung cancer. PLoS One. 2013;8(11):e8240. doi:10.1371/journal.pone.0080240
   Web of Science ®Google Scholar
• Warwick R, Mediratta N, Shackcloth M, et al. Preoperative red cell distribution width in patients undergoing pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(1):108–113. doi:10.1093/ejcts/ezt27523711463
   PubMed Web of Science ®Google Scholar
• Ichinose J, Murakawa T, Kawashima M, et al. Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small lung cancer. J Thorac Dis. 2016;8(12):3658–3666. doi:10.21037/jtd.2016.12.4428149561
   PubMed Web of Science ®Google Scholar
• Kos M, Hocazade C, Kos FT, et al. Evaluation of the effects of red blood cell distribution width on survival in lung cancer patients. Contemp Oncol (Pozn). 2016;20:153–157. doi:10.5114/wo.2016.6007227358595
   PubMed Web of Science ®Google Scholar
• Lembicz M, Gabryel P, Brajer-Luftmann B, et al. Comorbidities with non-small cell lung cancer: is there an interdisciplinary consensus needed to qualify patients for surgical treatment. Ann Thorac Med. 2018;13(2):101–107. doi:10.4103/atm.ATM_274_1729675061
   PubMed Web of Science ®Google Scholar
• Birim O, Maat APWM, Kappetein AP, et al. Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer. Eur J Cardiothorac Surg. 2003;23(1):30–34. doi:10.1016/S1010-7940(02)00721-212493500
   PubMed Web of Science ®Google Scholar
• Moro-Sibiliot D, Aubert A, Diab S, et al. Comorbidities and Charlson score in resected stage I non-small cell lung cancer. Eur Respir J. 2005;26(3):480–486. doi:10.1183/09031936.05.0014600416135732
   PubMed Web of Science ®Google Scholar
• Cheng X, Chen H. Commentary on the impact of postoperative complications on survival after lung cancer surgery. J Thorac Cardiovasc Surg. 2018;155(3):1265–1266. doi:10.1016/j.jtcvs.2017.10.12229198796
   PubMed Web of Science ®Google Scholar
• Shinohara S, Kobayashi K, Kasahara C, et al. Long-term impact of complications after lung resection in non small cell lung cancer surgery. J Thorac Dis. 2019;11(5):2024–2033. doi:10.21037/jtd.2019.04.9131285895
   PubMed Web of Science ®Google Scholar
• Fernandez FG, Kosinski AS, Furnary AP, et al. Differential effects of operative complications on survival following surgery for primary lung cancer. J Thorac Cardiovasc Surg. 2018;155(3):1254–1264. doi:10.1016/j.jtcvs.2017.09.14929221736
   PubMed Web of Science ®Google Scholar
• Hanagiri T, Takenaka M, Oka S, et al. Clinical significance of the number involved of lymph nodes in patients that underwent surgery for pathological stage III-N2 non- small cell lung cancer. J Cardiothorac Surg. 2011;6(1):144. doi:10.1186/1749-8090-6-14422027105
   PubMed Web of Science ®Google Scholar
• Legras A, Mordant P, Arame A, et al. Long term survival of patients with N2 lung cancer according to the pattern of lymphatic spread. Ann Thorac Surg. 2014;97(4):1156–1162. doi:10.1016/j.athoracsur.2013.12.04724582052
   PubMed Web of Science ®Google Scholar
• Sezen CB, Aksoy Y, Sonmezoglu Y, et al. Prognostic factors for survival in patients with completely resected pN2 non-small cell lung cancer. Acta Chir Belg. 2019;29:1–7. doi:10.1088/00015458.2019.1658355
   Google Scholar